Case Report
Published on 08 Oct 2025
Case report: Anlotinib plus oral etoposide: a potential salvage therapy based on insights from EGFR-TKI-resistant SCLC transformation PDX and clinical settings
in Thoracic Oncology
- 496 views
Case Report
Published on 08 Oct 2025
in Thoracic Oncology
Review
Published on 08 Oct 2025
in Viral Immunology
Review
Published on 08 Oct 2025
in Pulmonary Medicine
Original Research
Published on 08 Oct 2025
in Comparative Immunology
Original Research
Published on 08 Oct 2025
in Cancer Immunity and Immunotherapy
Original Research
Published on 08 Oct 2025
in Structural Materials
Case Report
Published on 08 Oct 2025
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Original Research
Published on 08 Oct 2025
in Psycho-Oncology
Original Research
Published on 08 Oct 2025
in Obstetrics and Gynecological Surgery
Original Research
Published on 08 Oct 2025
in Robot Learning and Evolution
Original Research
Published on 08 Oct 2025
in Analytical Chemistry
Case Report
Published on 08 Oct 2025
in Genitourinary Oncology
Original Research
Published on 08 Oct 2025
in Healthcare Professions Education
Original Research
Published on 08 Oct 2025
in STEM Education
Original Research
Published on 08 Oct 2025
in Brain Imaging Methods
Original Research
Published on 08 Oct 2025
in Ophthalmology